Price Range (₹)
Price Range (₹)
Issue Size (₹ in Cr.)
Minimum Quantity
Bidding Period
Tarsons Products Lts is a leading Indian life sciences company engaged in the designing, development, manufacturing and marketing of ‘consumables’, ‘reusables’ and ‘others’ including benchtop equipment, used in various laboratories across research organizations, academia institutes, pharmaceutical companies, Contract Research Organizations (“CROs”), Diagnostic companies and hospitals. They manufacture a range of quality labware products which helps advance scientific discovery and improve healthcare.
As of March 31, 2021, they had a diversified product portfolio with over 1,700 SKUs across 300 products.
There are no listed entities whose business portfolio is comparable with that of Tarsons Products business and comparable to their scale of operations.
They believe that, with over 36 years of experience in this space, they have successfully built ‘Tarsons’ into a leading Indian company in the plastic labware market in India and gained expertise in the production of a wide range of labware products.
They are among the top three labware manufacturing companies in India, providing an extensive range of laboratory consumables, reusables and ‘others’ product categories.
They have emphasized on building strong quality management systems in their manufacturing processes as well as the raw materials used for manufacturing their products. Failure to maintain compliance with these quality standards may disrupt their ability to supply products which meet their end customers’ requirements.
They identify and approve multiple third-party suppliers, from whom they procure raw materials, packaging material and services, including in relation to radiation and disinfection of their products.
There is a continued focus on product and process improvement. Maintaining high standards of process innovation and quality in manufacturing operations is critical to the brand and maintenance of long-term relationships with end use customers.
Indian Healthcare Industry Market
The Indian healthcare market has witnessed a growth of 9.1% in 2020 to reach ~USD 198 Bn. The Indian healthcare market is expected to register a huge growth of ~23% between 2020-2025 to reach ~USD 557 Bn by 2025 (Company DRHP; Frost & Sullivan).
Indian pharmaceutical companies - R&D spending
As per estimates, about USD 252 Bn worth of drug sales are likely to get off patent from 2020 to 2026. Some of the Indian companies are now well placed to capture this opportunity. With on-going developments, India has started focusing on selfreliance at a large scale.
India CRAMS Market (Contract Research and Manufacturing Services)
India is amongst the preferred destinations for outsourcing of research as well as manufacturing activities. New age CRAMS providers are able to cater to not just the pharmaceutical clients, but also biotech, agrochemicals, nutrition, animal health, consumer goods and others.
Retail Individual Investor | |
Non-Institutional Investor | |
Qualified Institutional Buyers | |
Overall |
Applications
refunds
Convenient investments
of application
For ICICI Bank linked A/c
For non ICICI Bank A/c
Go to the IPO section, select the IPO you want to apply from the list and click on ‘Apply’.
Fill in the quantity of the number of shares you want to buy. To apply at maximum price, check the cut-off price box and amount is auto calculated. If you want to apply at some other price within the price band, then you can enter the price manually by clicking on “Add bid” option.
Click on proceed to confirm the order. You can view the placed order under “order book”.
Choose the IPO you want to apply from the list. Click on Apply.
Fill in the quantity of shares. To apply at maximum price, check the cut-off price box and amount is auto calculated. If you want to apply at some other price within the price band, then you can enter the price manually by clicking on “Add bid” option.
Check the A/C, UPI details and click on proceed. You will get an UPI link by which payment can be made.
Trusted by
customers
Investments & Liability Products
Investment Basket
Access to
Disclaimer – I ICICI Securities Ltd. ( I-Sec). Registered office of I-Sec is at ICICI Securities Ltd. - ICICI Venture House, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400 025, India, Tel No : 022 - 6807 7100. I-Sec is acting as a distributor to solicit bond related products. All disputes with respect to the distribution activity, would not have access to Exchange investor redressal forum or Arbitration mechanism. The contents herein above shall not be considered as an invitation or persuasion to trade or invest. I-Sec and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon. Investments in securities market are subject to market risks, read all the related documents carefully before investing. The contents herein mentioned are solely for informational and educational purpose.